SIONYX BRINGS THE WONDERS OF THE NIGHT TO WILDLIFE ENTHUSIASTS

When nightfall arrives, wildlife enthusiasts, first responders, ranchers, and hunters alike must often cut their activities short. Whether it’s bird watching, performing a search and rescue, locating livestock, or going after the big kill, until now, no action camera existed to enhance these pursuits during both day and nighttime hours. Extend your endeavors deep in to the night with Aurora Night Vision by SiOnyx!
Aurora night vision captures monochrome or color videos and photos under extreme low light conditions at a price that’s affordable. Ideal for a wide range of applications, Aurora provides unparalleled capabilities to utility workers forced to work at night, to school buses traveling home after late night games, for ATV riders, cyclers and hikers roaming the range during the dark, and so much more.
Ruggedly built and powered by SiOnyx’s black silicon platform, Aurora is the world’s first small, low cost, high performance action camera with real night vision. Bring the wonders of the night to life with Aurora by SiOnyx!

Picture

Click here to download a high-res version

Download File


Read more at sionyx.com

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More